Latest News in the pharma Industry

Policy & Regulation

FDA Approves Jardiance Tablets for Adults with Type 2 Diabetes

FDA Approves Jardiance Tablets for Adults with Type 2 Diabetes

4 Aug 2014

Read more 
CHMP Issues Positive Opinion for Intravenous Formulation of Merck's Noxafil

CHMP Issues Positive Opinion for Intravenous Formulation of Merck's Noxafil

1 Aug 2014

Read more 
Successful FDA Inspection at Hovione’s API Manufacturing Plant in Cork, Ireland

Successful FDA Inspection at Hovione’s API Manufacturing Plant in Cork, Ireland

31 Jul 2014

Read more 
Consultation Launched on Proposed Changes to the ABPI Code of Practice for the Pharmaceutical Industry?

Consultation Launched on Proposed Changes to the ABPI Code of Practice for the Pharmaceutical Industry?

31 Jul 2014

Read more 
FDA Expands Approved Use of Imbruvica for Chronic Lymphocytic Leukemia

FDA Expands Approved Use of Imbruvica for Chronic Lymphocytic Leukemia

30 Jul 2014

Read more 
Salix and Pharming Announce FDA Approval of Ruconest

Salix and Pharming Announce FDA Approval of Ruconest

18 Jul 2014

Read more 
New Report Shows UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard

New Report Shows UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard

14 Jul 2014

Read more 
The Active Pharmaceutical Ingredient Committee (APIC) Publishes a Draft “How to do” Document on GDP

The Active Pharmaceutical Ingredient Committee (APIC) Publishes a Draft “How to do” Document on GDP

9 Jul 2014

Read more 
Japan Approves First All-Oral, Interferon- and Ribavirin-Free Hepatitis C Treatment, Daklinza  and Sunvepra Dual Regimen

Japan Approves First All-Oral, Interferon- and Ribavirin-Free Hepatitis C Treatment, Daklinza and Sunvepra Dual Regimen

7 Jul 2014

Read more 
FDA Outlines Expectations for Human Drug Compounders, Including Registered Outsourcing Facilities

FDA Outlines Expectations for Human Drug Compounders, Including Registered Outsourcing Facilities

2 Jul 2014

Read more 
FDA Approves Mannkind's Afrezza - a Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes

FDA Approves Mannkind's Afrezza - a Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes

30 Jun 2014

Read more 
Shire’s ADHD Medication Patents Found to Be Infringed and Valid by US District Court

Shire’s ADHD Medication Patents Found to Be Infringed and Valid by US District Court

25 Jun 2014

Read more